Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout

Clinical Trial ID NCT00663169

PubWeight™ 6.12‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00663169

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 2012 4.40
2 Canakinumab. MAbs 2010 1.16
3 Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer. Cancer Growth Metastasis 2015 0.90
Next 100